Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

Clinical trial NCT01013103 · COMPLETED

Trial details

NCT number: NCT01013103
Sponsor: Hippocration General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease HMG-CoA Reductase Inhibitor Toxicity Atherosclerosis Oxidative Stress Endothelial Dysfunction

Start date: 2007-10-01
Primary completion: 2012-02-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.